ANIK FY 2023 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$213M

FY 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$121M+6.1% YoY

Gross Profit

$83M68.3% margin

Operating Income

$844,0000.7% margin

Net Income

-$83M-68.4% margin

EPS (Diluted)

$-5.64

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$7M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$271M

Total Liabilities

$58M

Stockholders' Equity

$212M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$121M	$114M	+6.1%
Gross Profit	$83M	$73M	+12.7%
Operating Income	$844,000	$4M	-77.0%
Net Income	-$83M	-$15M	-456.3%